Skip to content

InfuSystem Holdings INFU Patient Services — Supplies and material costs

Other segment segments

Device Solutions
$4.48M-1.5%

Similar metrics at other companies

The Oncology Institute, Inc. logo
TOIMedical supplies and other — Direct costs
$8.28M+420%
Conduent Incorporated logo
CNDTServices and supplies
$174M+1.2%
The GEO Group logo
GEOInternational Services — Medical Services And Supplies
$0
ARD
ARDTReportable Segment — Supplies
$268.55M+3.7%
Tenet Healthcare logo
THCSupplies Expense
$961M+6.0%
Encompass Health Corporation logo
EHCSupplies Expense
$64.3M+3.4%

Other financials

Income statement

See full
Revenue$33.7M-3.0%
Gross profit$19.7M+2.7%
Operating income$1.6M+157%
Net income$1.0M+481%
EPS (diluted)$0.05+600%

Balance sheet

See full
Cash & equivalents$2.1M+39.8%
Total debt$24.1M-30.4%
Total equity$58.7M+6.5%
Total assets$98.7M-5.4%

Cash flow

See full
Operating cash flow$970.0K-45.5%
CapEx$157.0K+19.8%
Free cash flow$813.0K-50.7%

Valuation

See full
Market cap$205.05M+51.3%
Enterprise value$227.04M+36.2%
P/E25.9×-0.8×
P/S1.4×+0.5×

Profitability

See full
Gross margin56.7%+3.6pp
Operating margin9.1%+3.0pp
Net margin5.6%+3.2pp
FCF margin16.2%+1.0pp

Returns & leverage

See full
Return on equity13.9%+8.0pp
Debt / equity0.4×-0.2×
Current ratio2.1×-0.1×

Where this comes from

Reported directly by InfuSystem Holdings in its filing.

Tagged under the XBRL concept us-gaap:SuppliesExpense.

The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InfuSystem Holdings's patient services — supplies and material costs.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InfuSystem Holdings's patient services — supplies and material costs?
InfuSystem Holdings (INFU) reported patient services — supplies and material costs of $5.86M in Q1 2026.
How has InfuSystem Holdings's patient services — supplies and material costs changed year-over-year?
InfuSystem Holdings's patient services — supplies and material costs increased by 5.8% year-over-year, from $5.53M to $5.86M.
What is the long-term trend for InfuSystem Holdings's patient services — supplies and material costs?
Over 2 years (2023 to 2025), InfuSystem Holdings's patient services — supplies and material costs has grown at a 8.1% compound annual growth rate (CAGR), from $20.08M to $23.48M.
What does patient services — supplies and material costs mean?
The direct costs associated with the supplies and medical materials required to deliver services within the Patient Services segment. Monitoring this helps evaluate the segment's direct cost efficiency and the impact of supply chain pricing on gross margins.